Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curtis Hughesman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Biochemistry|February 6, 2015
A new general model for predicting melting thermodynamics of complementary and mismatched B-form duplexes containing locked nucleic acids: application to probe design for digital PCR detection of somatic mutationsCurtis Hughesman, Kareem Fakhfakh, Roza Bidshahri, et al.
JTO Clinical and Research Reports|April 7, 2025
Brief Report: Real-World Treatment Patterns and Clinical Outcomes for Patients With Advanced ALK-Rearranged NSCLC in British ColumbiaPeiyao Wang, Curtis Hughesman, Stephen Yip, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2020
No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective AnalysisWasithep Limvorapitak, Jeremy Parker, Curtis Hughesman, et al.
International Journal of Surgical Pathology|April 28, 2022
Metastatic Small Bowel Adenocarcinoma Mimicking a Primary Ovarian Mucinous Tumour - Clinical, Radiologic, Pathologic and Molecular CorrelationHang Yang, Ren Yuan, Deepu Alex, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapySelina K Wong, Deepu Alex, Ian Bosdet, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing PlatformNorbert Banyi, Deepu Alex, Curtis Hughesman, et al.
Frontiers in Pharmacology|September 25, 2023
Implementation of pharmacogenetic testing in oncology: <i>DPYD</i>-guided dosing to prevent fluoropyrimidine toxicity in British ColumbiaAngela Wu, Helen Anderson, Curtis Hughesman, et al.
The Journal of Molecular Diagnostics : JMD|January 15, 2016
Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative AssayRoza Bidshahri, Dean Attali, Kareem Fakhfakh, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Translational Lung Cancer Research|September 21, 2020
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomesAlexandra Pender, Curtis Hughesman, Elaine Law, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biochemistry|February 6, 2015
A new general model for predicting melting thermodynamics of complementary and mismatched B-form duplexes containing locked nucleic acids: application to probe design for digital PCR detection of somatic mutationsCurtis Hughesman, Kareem Fakhfakh, Roza Bidshahri, et al.
JTO Clinical and Research Reports|April 7, 2025
Brief Report: Real-World Treatment Patterns and Clinical Outcomes for Patients With Advanced ALK-Rearranged NSCLC in British ColumbiaPeiyao Wang, Curtis Hughesman, Stephen Yip, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2020
No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective AnalysisWasithep Limvorapitak, Jeremy Parker, Curtis Hughesman, et al.
International Journal of Surgical Pathology|April 28, 2022
Metastatic Small Bowel Adenocarcinoma Mimicking a Primary Ovarian Mucinous Tumour - Clinical, Radiologic, Pathologic and Molecular CorrelationHang Yang, Ren Yuan, Deepu Alex, et al.
Lung Cancer (Amsterdam, Netherlands)|March 5, 2021
MET exon 14 skipping mutation positive non-small cell lung cancer: Response to systemic therapySelina K Wong, Deepu Alex, Ian Bosdet, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Improving Time-to-Treatment for Advanced Non-Small Cell Lung Cancer Patients through Faster Single Gene EGFR Testing Using the Idylla™ EGFR Testing PlatformNorbert Banyi, Deepu Alex, Curtis Hughesman, et al.
Frontiers in Pharmacology|September 25, 2023
Implementation of pharmacogenetic testing in oncology: <i>DPYD</i>-guided dosing to prevent fluoropyrimidine toxicity in British ColumbiaAngela Wu, Helen Anderson, Curtis Hughesman, et al.
The Journal of Molecular Diagnostics : JMD|January 15, 2016
Quantitative Detection and Resolution of BRAF V600 Status in Colorectal Cancer Using Droplet Digital PCR and a Novel Wild-Type Negative AssayRoza Bidshahri, Dean Attali, Kareem Fakhfakh, et al.
Translational Lung Cancer Research|August 14, 2023
First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemicSuganija Lakkunarajah, Pauline T Truong, Jeffrey N Bone, et al.
Translational Lung Cancer Research|September 21, 2020
EGFR circulating tumour DNA testing: identification of predictors of ctDNA detection and implications for survival outcomesAlexandra Pender, Curtis Hughesman, Elaine Law, et al.
Pageof 2